More articles from Radionuclide Therapy

You have access
Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
Caio Vinicius Oliveira, Tatiane Sabriela Cagol Camozzato, Patricia Fernanda Dorow and Jéssica Pasqueta

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 233-239; DOI: https://doi.org/10.2967/jnmt.121.263502
You have access
Analysis of Radiometry on Patients Undergoing Radioactive Iodine Therapy
Pietro Paolo de Barros, Tatiane Sabriela Cagol Camozzato, Tiago Jahn, Flávio Augusto Penna Soares, Letícia Machado da Silva, Jacqueline de Aguiar Soares and Marco Antonio Neiva Koslosky

Journal of Nuclear Medicine Technology March 1, 2021, 49 (1) 75-81; DOI: https://doi.org/10.2967/jnmt.120.246512
You have access
Review of Palliative ²²³Ra in Metastatic Castration-Resistant Prostate Cancer: Experience at West Virginia University Cancer Center
Ruta Arays, Zeeshan Ahmad, Lorinda Howard, Kenneth Veselicky, Joanna Kolodney, SijinWen and Thomas Hogan

Journal of Nuclear Medicine Technology March 1, 2021, 49 (1) 70-74; DOI: https://doi.org/10.2967/jnmt.120.254474
You have access
¹⁷⁷Lu-EDTMP for Treatment of Bone Pain in Patients with Disseminated Skeletal Metastases
Ajit S. Shinto, Deepu Shibu, Koramadai Karuppusamy Kamaleshwaran, Tapas Das, Sudipta Chakraborty, Sharmila Banerjee, Palanisamy Thirumalaisamy, Pravin Das and Ganesh Veersekar

Journal of Nuclear Medicine Technology March 1, 2014, 42 (1) 55-61; DOI: https://doi.org/10.2967/jnmt.113.132266

Main menu